Safi Biotherapeutics Inc Press Releases

• Published on December 18, 2024 - 13:15 GMT

  

  Safi Biotherapeutics Granted Rare Pediatric Disease Designation and Orphan Drug Designation from the U.S. FDA

  Designations support use of manufactured red blood cells in sickle cell disease chronic transfusion therapy CAMBRIDGE, MA, UNITED STATES, December 18, 2024 /⁨EINPresswire.com⁩/ -- Safi Biotherapeutics, a biotech company producing stem-cell derived, human …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on September 11, 2024 - 20:00 GMT

  

  Safi Biotherapeutics Secures $5M in Seed Funding to Accelerate Plans to Grow Blood for Acute and Chronic Transfusions

  Developer of world-leading capabilities in the hyper-efficient production of manufactured red blood cells at viable economics. CAMBRIDGE, MA, UNITED STATES, September 11, 2024 /⁨EINPresswire.com⁩/ -- Founded by former DARPA, Vertex, MIT, and MGH leaders, …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on January 5, 2024 - 13:00 GMT

  

  Safi Biotherapeutics Solidifies Leading Position in Red Blood Cell Biomanufacturing with Acquisition of EryPharm Assets

  CAMBRIDGE, MA, UNITED STATES, January 5, 2024 /⁨EINPresswire.com⁩/ -- Safi Biotherapeutics (“Safi”), a leader in the field of allogeneic biomanufacture of blood cells, proudly announces the successful completion of an agreement to acquire all assets of …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on August 4, 2022 - 09:00 GMT

  

  Safi Biosolutions rebranding as Safi Biotherapeutics

  CAMBRIDGE, MA, UNITED STATES, August 4, 2022 /⁨EINPresswire.com⁩/ -- To better align with Safi Biosolution’s noble and ambitious mission to produce blood cells at multi-unit transfusion scale with viable economics for therapeutic indications, the company …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on March 24, 2022 - 16:00 GMT

  

  Safi Biosolutions developing alternatives to donated blood as part of USU 4D Bio3 On-Demand Blood program

  CAMBRIDGE, MA, UNITED STATES, March 24, 2022 /⁨EINPresswire.com⁩/ -- The Geneva Foundation (Geneva), a 501(c)3 non-profit that provides innovative scientific research and exceptional program management, recently announced the award of an additional $12 …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...